Search - tctmd.com

Displaying 1 - 15 of 15

Sort: Relevancy | Date

News Daily News

Even on Tafamidis, ATTR-CM Patients Face High Mortality Over Time

Michael O'Riordan

February 13, 2025

News Daily News

Reduced Vascular Load, Better RV Function With Dapagliflozin in HFpEF

Michael O'Riordan

July 26, 2024

News Daily News

TAVI Outcomes Linked to LV Recovery in Patients With Severe Dysfunction

Michael O'Riordan

May 06, 2024

News Daily News

Most Takotsubo Patients Die From CV Causes, but Standard Meds No Help

Todd Neale

January 11, 2024

News Daily News

Concerning or Reassuring? Long After COVID-19, CMR Still Yields Clues

Michael O'Riordan

October 03, 2022

News Daily News

The Hunt for Protein Culprits in COVID-19’s Cardiac Complications

Michael O'Riordan

May 06, 2022

News Daily News

CVD Hospitalizations Spiked in Aftermath of 2020 US Election

Michael O'Riordan

April 22, 2022

News Daily News

Continue ACE Inhibitors/ARBs in COVID-19, New Study Confirms

Michael O'Riordan

April 02, 2021

News Daily News

Higher Risk of HF After ACS for Women Previously on Beta-blockers

Michael O'Riordan

July 16, 2020

News Daily News

LEADER Analysis Reassures on Liraglutide in Diabetic Patients With Heart Failure

Shelley Wood

March 10, 2020

News Daily News

RAS Inhibition After TAVR Gains More Support, but RCT Still Needed

Todd Neale

July 29, 2019

News Daily News

Rates of Heart Failure After Acute MI Declining, Statewide Analysis Shows

Michael O'Riordan

April 05, 2018

News Daily News

LV Diastolic Dysfunction Linked With Higher Mortality Post-TAVR

Yael L. Maxwell

March 01, 2018

News Daily News

Heart Failure Risk Following 'Silent' MI Warrants Scrutiny: ARIC Analysis

Caitlin E. Cox

January 08, 2018

News Daily News

Beta-Blockers Questioned Anew in Post-MI Patients Without Heart Failure

L.A. McKeown

May 31, 2017

Advertisement

Even on Tafamidis, ATTR-CM Patients Face High Mortality Over Time

Reduced Vascular Load, Better RV Function With Dapagliflozin in HFpEF

TAVI Outcomes Linked to LV Recovery in Patients With Severe Dysfunction

Most Takotsubo Patients Die From CV Causes, but Standard Meds No Help

Concerning or Reassuring? Long After COVID-19, CMR Still Yields Clues

The Hunt for Protein Culprits in COVID-19’s Cardiac Complications

CVD Hospitalizations Spiked in Aftermath of 2020 US Election

Continue ACE Inhibitors/ARBs in COVID-19, New Study Confirms

Higher Risk of HF After ACS for Women Previously on Beta-blockers

LEADER Analysis Reassures on Liraglutide in Diabetic Patients With Heart Failure

RAS Inhibition After TAVR Gains More Support, but RCT Still Needed

Rates of Heart Failure After Acute MI Declining, Statewide Analysis Shows

LV Diastolic Dysfunction Linked With Higher Mortality Post-TAVR

Heart Failure Risk Following 'Silent' MI Warrants Scrutiny: ARIC Analysis

Beta-Blockers Questioned Anew in Post-MI Patients Without Heart Failure

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content